Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Medical Faculty Heidelberg, University of Heidelberg, Germany.
Mol Oncol. 2021 Aug;15(8):1986-1994. doi: 10.1002/1878-0261.12924. Epub 2021 Mar 10.
Recent meta-analyses of randomized controlled trials (RCTs) have demonstrated significant reduction in cancer mortality by vitamin D supplementation. We estimated costs and savings for preventing cancer deaths by vitamin D supplementation of the population aged 50+ years in Germany. Our analysis is based on national data on cancer mortality in 2016. The number of preventable cancer deaths was estimated by multiplying cancer deaths above age 50 with the estimated proportionate reduction in cancer mortality derived by vitamin D supplementation according to meta-analyses of RCTs (13%). Saved costs were estimated by multiplying this number by estimated end-of-life cancer care costs (€40 000). Annual costs of vitamin D supplementation were estimated at 25€ per person above age 50. Comprehensive sensitivity analyses were conducted. In the main analysis, vitamin D supplementation was estimated to prevent almost 30 000 cancer deaths per year at approximate costs of €900 million and savings of €1.154 billion, suggesting net savings of €254 million. Our results support promotion of supplementation of vitamin D among older adults as a cost-saving approach to substantially reduce cancer mortality.
最近的随机对照试验(RCT)荟萃分析表明,维生素 D 补充剂可显著降低癌症死亡率。我们估计了德国 50 岁以上人群补充维生素 D 预防癌症死亡的成本和节省。我们的分析基于 2016 年全国癌症死亡率数据。通过将 50 岁以上癌症死亡人数乘以根据 RCT 荟萃分析得出的维生素 D 补充剂估计的癌症死亡率成比例降低(13%),来估计可预防的癌症死亡人数。通过将这个数字乘以估计的临终癌症护理成本(4 万欧元),来估计节省的成本。估计每人每年补充维生素 D 的费用为 50 岁以上人群每人 25 欧元。进行了全面的敏感性分析。在主要分析中,估计每年补充维生素 D 可预防近 30000 例癌症死亡,费用约为 9 亿欧元,节省 115.4 亿欧元,表明净节省 2.54 亿欧元。我们的研究结果支持在老年人中推广补充维生素 D,这是一种节省成本的方法,可以大大降低癌症死亡率。